收藏切换
American Pediatric Study Plan and Implications for early clinical research in China
收藏切换
Hongcan HAN, Jun WANG*
Chinese Journal of Pharmaceuticals | 2022, 53(11) : 1612 - 1615
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2022, 53(11): 1612-1615
American Pediatric Study Plan and Implications for early clinical research in China
Full
Hongcan HAN, Jun WANG*
Affiliations
  • Center of Drug Evaluation, National Medical Products Administration, Beijing 100022
Published: 2022-11-10 doi: 10.16522/j.cnki.cjph.2022.11.014
Outline
收藏切换

The United States has passed legislation to promote the development of pediatric drugs, requiring R&D companies to submit pediatric study plan in the early stage of research and development. The purpose is to allow R&D companies to determine the needs of pediatric applications in the early stage of clinical research. The specific requirements of the US Food and Drug Administration on pediatric study plan, including the research strategy, the timing of the research and the content of the submitted data, can be used as a reference for Chinese R&D enterprises. Research and development companies can plan pediatric research as early as possible in early clinical research and development, effectively utilize the strategy of extrapolation from adults to children, communicate with regulatory agencies as early as possible, improve research and development efficiency, and speed up the marketing of pediatric drugs.

pediatric study plan  /  clinical research  /  communication meeting  /  extrapolation
韩鸿璨, 王骏. 美国儿科研究计划要求对我国早期临床研发的启示. 中国医药工业杂志, 2022 , 53 (11) : 1612 -1615 . DOI: 10.16522/j.cnki.cjph.2022.11.014
Hongcan HAN, Jun WANG. American Pediatric Study Plan and Implications for early clinical research in China[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (11) : 1612 -1615 . DOI: 10.16522/j.cnki.cjph.2022.11.014
Year 2022 volume 53 Issue 11
65
14
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.11.014
  • Receive Date:2022-08-14
  • Online Date:2026-11-12
  • Published:2022-11-10
Article Data
Affiliations
History
  • Received:2022-08-14
Affiliations
    Center of Drug Evaluation, National Medical Products Administration, Beijing 100022
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.11.014
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT